URETERAL STENTS MARKET ANALYSIS

Ureteral Stents Market, by Product Type (Double Pigtail Stents and Multiloop Stents), by Material Type (Metal Stents and Polymer Stents (Silicone Ureteral Stents, Hybrid Ureteral Stents, and Polyurethane Ureteral Stents)), by Application (Kidney Stones (Ureteroscopy, Lithotripsy, and Percutaneous Nephrolithotomy), Kidney Transplantation, Urinary Incontinence, Tumors, and Others), by End User (Hospitals, Gastrointestinal Surgery Clinics, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Jan 2023
Code : CMI2172
Pages :197
Formats :
Excel and PDF
Industry : Medical Devices

Ureteral Stents MarketSize and Trends

Global ureteral stents market is estimated to be valued at US$ 498.2 Mn in 2022 and is expected to exhibit a CAGR of 5.6% over the forecast period (2022-2030).

Figure 1: Global Ureteral Stents Market Share (%) Analysis, By Product Type, 2022

Increasing incidence of kidney diseases is expected to drive the global ureteral stents market growth over the forecast period.

Increasing incidence of kidney diseases is expected to drive the global ureteral stents market growth over the forecast period. For instance, According to data published by the United States Renal Data System (USRDS), almost 786,000 persons in the United States suffer from end-stage renal disease (ESRD), with 71% requiring dialysis and 29% requiring a kidney transplant. In 2018, 131,636 people in the United States were diagnosed with ESRD, up 2.3% from 2017. Between 2017 and 2018, the unadjusted ESRD incidence per million increased by 1.5%, however the adjusted ESRD incidence per million increased by only 0.2%.

Increasing product approvals by regulatory authorities is expected to drive the global ureteral stents market growth over the forecast period.

Increasing product approvals by regulatory authorities is expected to drive the global ureteral stents market growth over the forecast period. For instance, May 14, 2018, Allium Medical, an Israel-based medical device company that specializes in minimally invasive technologies and solutions, announced that it received regulatory clearance from the China Food and Drug Administration (CFDA) to market its portfolio of urological systems in China. The company has an exclusive strategic agreement with a distribution organization in China\'s urology market.

Global Ureteral Stents Market- Impact of the Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic is expected to hamper the global ureteral stents market growth, owing to delayed surgeries or elective surgeries. For instance, on July 6, 2021, according to an article published in the PLOS ONE, a scientific journal on the impact of COVID-19 on elective surgery in Finland observed data indicates that the incidence of elective surgery decreased substantially when the first COVID-19 wave began in March 2020. . In 2020, Waiting times for gastrointestinal and genitourinary disorders and neoplasms were longer.